The FDA is seeking feedback on a list of patient preference areas that it put together to help them take into account patients’ views as they make regulatory decisions about medical devices. Included on this list of patient preference areas is “Ear, Nose, and Throat: Treatments for moderate to severe hearing loss (implanted hearing devices vs. other treatment options).”
The FDA is seeking information or qualitative or quantitative assessments of whether patients prefer certain alternatives, outcomes or choices over others in terms of their health.
The FDA wants to understand how patients view the risks and benefits of a technology or treatment differently from how the risks and benefits are viewed by health-care professionals and caregivers and whether differences in patient perspectives are not well understood due to a variety of factors.
Check out their request for comments on the Federal Register.
Recent Posts
Using Supply and Demand to Identify Shortages in the Hearing Health Care Professional Workforce
Garuccio, Ukert, and Arnold (2025) analyzed changes in the hearing healthcare (HHC) workforce between 2012 and 2022. They also identified areas that had a shortage…
Hearing Loss Linked to Lower Income in Young Adults
Hearing loss, as well as tinnitus, has been correlated with socioeconomic factors such as reduced income and unemployment (Nadler, 2023). This correlation is even more impactful…
Tympanoplasty in Children: A Retrospective Study
The purpose of a tympanoplasty is to repair a hole in a tympanic membrane (TM). An important functional outcome of this surgery is to improve…